So, it's a good time to think about the evolving role and activities of GPOs, which is why CBI is offering a one-day conference in December called GPO and Institutional Sales Strategy Summit. Speakers on the agenda come from such companies as Bayer Healthcare, Bristol-Myers Squibb, Institute for Integrated Healthcare, McKesson Specialty Health, Novartis, Sisters of Providence Health System, the Journal of Healthcare Contracting and ACO Insights, VHA, and more.
Drug Channels readers can register with promo code NMX542 by Friday, October 11, to save $300 on registration. Thanks, CBI!
OFFICIAL DESCRIPTION FROM CBI
The GPO and Institutional Sales Strategy Summit is the first and only event that equips pharmaceutical and biotech companies to fully realize opportunities with GPOs and IDNs as key stakeholders for commercial strategy. As manufacturers continue to utilize secondary data to size up and segment the U.S. IDN market (such as sales volume, span of control and level of prescribing influence), an account-based commercialization and sales strategy is critical to success in a hyper competitive and price sensitive marketplace.
Hear Expert Insights on:
- The impact of healthcare reform on sales reps
- Strategies for contracting with GPOs and IDNs
- Institutional pharmacy initiatives
- Manufacturer relationship analysis
- Fair market value and pricing structure
- Downstream supply chain costs
- GPO value and benefit design
You will benefit from attending this event if you are a senior-level executive, director or manager from a pharmaceutical, biotech or medical device manufacturer with responsibilities or involvement in the following areas:
- National Accounts
- Institutional/Hospital Sales
- GPO/IDN Sales
- Managed Markets
- Pharmacy Relations